Five Prime Therapeutics, Inc. FPRX

Full chart Compare
Set alert

Price alert · FPRX

All alert types
— —

Day range unavailable

52-week range unavailable

Revenue & Expenses

Revenue by
Other Income → Expenses: $1.91MIncome Tax Benefit → Expenses: $6.63MExpenses → Selling, General & Admin: $40.56MExpenses → Research & Development: $65.49MCollaboration → Revenue: $8.18MGross Profit → Expenses: $13.18MRevenue → Gross Profit: $13.18MLicense → Revenue: $5.00MNet Loss → Expenses: $84.33MOther Income$1.91MIncome Tax Benefit$6.63MGross Profit$13.18MNet Loss$84.33MExpenses$106.05MSelling, General & Admin$40.56MResearch & Development$65.49MRevenue$13.18MCollaboration$8.18MLicense$5.00M

Latest period ending Dec 31, 2020 · select a line to chart its full history

Annual income statement

FPRX annual income statement
Fiscal yearFY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017FY 2016 Dec 31, 2016
13.18M14.87M49.87M39.51M30.69M
13.18M14.87M49.87M39.51M30.69M
13.18M14.87M49.87M39.51M30.69M
106.05M156.81M196.02M190.91M129.90M
65.49M114.06M156.35M150.91M94.07M
40.56M42.75M39.67M40.00M35.83M
-92.87M-141.94M-146.16M-151.40M-99.21M
-6.63M001.70M-31.05M
-84.33M-137.20M-140.45M-150.22M-65.70M
-84.33M-137.20M-140.45M-150.22M-65.70M
-84.33M-137.20M-140.45M-150.22M-65.70M
-84.33M-137.20M-140.45M-150.22M-65.70M
-2.29-3.92-4.13-5.38-2.44
-2.29-3.92-4.13-5.38-2.44
-2.29-3.92-4.13-5.38-2.44
-90.96M-137.20M-140.45M-148.52M-96.75M
-90.96M-137.20M-140.45M-148.52M-96.75M
36.83M34.97M33.98M27.95M26.95M
36.83M34.97M33.98M27.95M26.95M